Maintenance treatment for GERD: Residual symptoms are associated with psychological distress

Digestion

Volumn 77, Issue 3-4, 2008, Pages 207-213

  Van Der Velden, A W ^a   De Wit, N J ^a   Quartero, A O ^a   Grobbee, D E ^a   Numans, M E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Acid suppressive therapy; Gastroesophageal reflux disease; Psychological factors; Quality of life; Refractory symptoms

Indexed keywords

CIMETIDINE; ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE; RANITIDINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ANAMNESIS; AREA UNDER THE CURVE; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DISTRESS SYNDROME; EXERCISE; FEMALE; GASTROESOPHAGEAL REFLUX; GENDER; HOSTILITY; HUMAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MENTAL STRESS; MINIMAL RESIDUAL DISEASE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RECEIVER OPERATING CHARACTERISTIC; SHORT FORM 36; SMOKING; SOMATIZATION;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH STATUS INDICATORS; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL;

EID: 50149096408     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000143796     Document Type: Article

References (38)

1. Hurenkamp GJ, Grundmeyer HG, Bindels PJ, Tytgat GN, van der Hulst RW: How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practices. J Fam Pract 2002;51:241-245.
2. van Pinxteren B, Numans ME, Bonis PA, Lau J: Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2006;3:CD002095.
3. Inadomi JM, McIntyre L, Bernard L, Fendrick AM: Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol 2003;98:1940-1944.
4. Fass R, Shapiro M, Dekel R, Sewell J: Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next? Aliment Pharmacol Ther 2005;22:79-94.
5. Raghunath AS, O'Morain C, McLoughlin RC: Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 2005;22(suppl 1):55-63.
6. Ålander T, Svardsudd K, Johansson SE, Agreus L: Psychological illness is commonly associated with functional gastrointestinal disorders and is important to consider during patient consultation: a population-based study. BMC Med 2005;3:8.
7. Baker LH, Lieberman D, Oehlke M: Psychological distress in patients with gastroesophageal reflux disease. Am J Gastroenterol 1995;90:1797-1803.
8. Locke GR, Weaver AL, Melton LJ, Talley NJ: Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004;99:350-357.
9. Johnston BT, Lewis SA, Collins JS, McFarland RJ, Love AH: Acid perception in gastrooesophageal reflux disease is dependent on psychosocial factors. Scand J Gastroenterol 1995;30:1-5.
10. Naliboff BD, Mayer M, Fass R, Fitzgerald LZ, Chang L, Bolus R, Mayer EA: The effect of life stress on symptoms of heartburn. Psychosom Med 2004;66:426-434.
11. Wright CE, Ebrecht M, Mitchell R, Anggiansah A, Weinman J: The effect of psychological stress on symptom severity and perception in patients with gastro-oesophageal reflux. J Psychosom Res 2005;59:415-424.
12. Kaltenbach T, Crockett S, Gerson LB: Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 2006;166:965-971.
13. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA: Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006;354:2340-2348.
14. Talley NJ, Fullerton S, Junghard O, Wiklund I: Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001;96:1998-2004.
15. Derogatis LR, Rickels K, Rock AF: The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976;128:280-289.
16. Ettema JHM, Arrindell WA: SCL-90: Manual for a Multidimensional Indicator of Psycho-Pathology (in Dutch). Lisse, Swets & Zeitlinger, 2003, pp 97, 103.
17. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E: Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998;51:1055-1068.
18. Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M: The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1159-1165.
19. Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey Manual and Interpretation Guide. Boston, New England Medical Center, The Health Institute, 1993, pp 6:16.
20. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
21. Dean BB, Gano AD, Knight K, Ofman JJ, Fass R: Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004;2:656-664.
22. Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H, Junghard O, Lauritsen K, Lundell L, Pedersen SA, Stubberod A: Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997;32:974-979.
23. Wiklund I, Carlsson R, Carlsson J, Glise H: Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials. Scand J Gastroenterol 2006;41:288-293.
24. Johnston BT, Lewis SA, Love AH: Psychological factors in gastro-oesophageal reflux disease. Gut 1995;36:481-482.
25. van Oudenhoven L, Demyttenaere K, Tack J, Aziz Q: Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004;18:663-680.
26. Hatlebakk JG, Katz PO, Camacho-Lobato L, Castell DO: Proton pump inhibitors: better acid suppression when taken before a meal than without a meal. Aliment Pharmacol Ther 2000;14:1267-1272.
27. Kuo B, Castell DO: Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol 1996;91:1532-1538.
28. Gunaratnam NT, Jessup TP, Inadomi J, Lascewski DP: Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2006;23:1473-1477.
29. Bate CM, Booth SN, Crowe JP, Hepworth-Jones B, Taylor MD, Richardson PD: Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis? Aliment Pharmacol Ther 1993;7:501-507.
30. Meineche-Schmidt V: Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption. Am J Gastroenterol 2004;99:1050-1058.
31. Moretzsohn LD, Brito EM, Reis MS, Coelho LG, Castro LP: Assessment of effectiveness of different dosage regimens of pantoprazole in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitis. Arq Gastroenterol 2002;39:123-125.
32. Derogatis LR, Melisaratos N: The Brief Symptom Inventory: an introductory report. Psychol Med 1983;13:595-605.
33. Terluin B, van Marwijk HW, Ader HJ, de Vet HC, Penninx BW, Hermens ML, van Boeijen CA, van Balkom AJ, van der Klink JJ, Stalman WA: The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. BMC Psychiatry 2006;6:34.
34. Clouse RE, Lustman PJ: Use of psychopharmacological agents for functional gastrointestinal disorders. Gut 2005;54:1332-1341.
35. Otaka M, Jin M, Odashima M, Matsuhashi T, Wada I, Horikawa Y, Komatsu K, Ohba R, Oyake J, Hatakeyama N, Watanabe S: New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther 2005;21(suppl 2):42-46.
36. Schmulson MJ, Valdovinos MA: Current and future treatment of chest pain of presumed esophageal origin. Gastroenterol Clin North Am 2004;33:93-105.
37. Kamolz T, Granderath FA, Bammer T, Pasiut M, Pointner R: Psychological intervention influences the outcome of laparoscopic anti-reflux surgery in patients with stress-related symptoms of gastroesophageal reflux disease. Scand J Gastroenterol 2001;36:800-805.
38. Donald-Haile J, Bradley LA, Bailey MA, Schan CA, Richter JE: Relaxation training reduces symptom reports and acid exposure in patients with gastroesophageal reflux disease. Gastroenterology 1994;107:61-69.